Tepezza Hearing Loss

In litigation Mass-tort payouts ($50k+) mass_tort · pharma

Tepezza hearing loss - MDL alleges the thyroid-eye-disease drug causes permanent hearing damage

Eligibility hint

Were treated with Tepezza infusions and developed hearing loss or tinnitus

Estimated payout range

$50,000 – $1,000,000

Current score

0.60 / 1.00

Official source

View source →

Tepezza (teprotumumab), a Horizon Therapeutics infusion drug for thyroid eye disease, is alleged to cause permanent hearing loss and tinnitus that the label failed to adequately warn about. The federal cases are consolidated in an MDL in the Northern District of Illinois. Eligibility centers on having been treated with Tepezza infusions and later developing hearing loss or tinnitus.

Recent signals

CL filing: In Re Instructure Data Breach Litigation courtlistener_search · 2026-08-15
FAERS: tepezza - Exophthalmos, Muscle spasms, Autophony, Lacrimation increased, Ocular hyperaemia fda_faers · 2026-08-04
FAERS: tepezza - Hypoacusis, Nonspecific reaction fda_faers · 2026-08-04
FAERS: tepezza - Toxic goitre fda_faers · 2026-08-04
FAERS: tepezza - Toxic goitre, Depression, Anxiety, Retinal disorder, Thyroxine free decreased fda_faers · 2026-08-04
FAERS: tepezza - Exophthalmos, Diplopia, Thyroid disorder fda_faers · 2026-08-04
FAERS: tepezza - Retinal detachment, Fatigue, Off label use, Decreased appetite, Taste disorder fda_faers · 2026-08-04
FAERS: tepezza - Muscle spasms, Dry skin, Tinnitus, Tinnitus fda_faers · 2026-08-04
FAERS: tepezza - Breast cancer fda_faers · 2026-08-04
Eye Disease Medication Tepezza Linked to Hearing Loss | Console and Associates, P.C. - JD Supra google_news · 2026-08-04

Brands: horizon therapeuticsamgen
Products: tepezzateprotumumabthyroid eye diseasehearing losstinnitus

Frequently asked questions

Who qualifies for the Tepezza Hearing Loss case?

You may qualify if the following applies to you: Were treated with Tepezza infusions and developed hearing loss or tinnitus. Eligibility criteria can change as the case develops.

How much could a Tepezza Hearing Loss claim be worth?

Estimated payouts range from $50,000 to $1,000,000 depending on individual circumstances. These are estimates based on comparable outcomes, not guarantees.

What is the current status of the Tepezza Hearing Loss case?

In litigation. Tepezza (teprotumumab), a Horizon Therapeutics infusion drug for thyroid eye disease, is alleged to cause permanent hearing loss and tinnitus that the label failed to adequately warn about. The federal cases are consolidated in an MDL in the Northern District of Illinois. Eligibility centers on having been treated with Tepezza infusions and later developing hearing loss or tinnitus.

How do I check whether I'm included?

Take the free 30-second audit at https://getclaimscout.com/audit and claimscout matches the brands and products you've used against every active class action settlements and mass torts it tracks, or review the eligibility details at https://getclaimscout.com/matters/tepezza-hearing-loss.

Think this might apply to you?
Take a 30-second audit and we'll match every brand you've used against active settlements.

Start audit →

On iPhone? Get the Claimscout app and follow this settlement for updates.

Building an AI agent? This matter is available as JSON at https://getclaimscout.com/api/v1/matters/tepezza-hearing-loss, and the full registry is at /api/v1/matters. Agent quickstart: /llms.txt. Schema: /openapi.json.